Stephen Poor MBBS, MRCOphth

Stephen Poor is a physician-scientist (UK-trained ophthalmologist) with over 20 years of drug discovery and development experience. Current role is Head of Translational Medicine at Apellis. Broad responsibilities include clinical trial leadership for GA and Alzheimer’s programs, BD&L, endpoint strategy, clinical trial optimization, and technology innovation. Previous roles @ Novartis include Head of Retinal Pharmacology, Director of External Innovation, and Global Program Clinical Head for Ophthalmology.